Skip to content

A prospective multicenter clinical study: Effects of varibility in intestinal flora on systemic immunity and prognosis in patients with persistent inflammatory immunosuppressive catabolism syndrome

A prospective multicenter clinical study: Effects of varibility in intestinal flora on systemic immunity and prognosis in patients with persistent inflammatory immunosuppressive catabolism syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017889
Enrollment
Unknown
Registered
2018-08-20
Start date
2018-10-31
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent inflammation, immunosuppression,catabolism syndrome

Interventions

Case series:Probiotics

Sponsors

Ruijin Hospital North Compus, Shanghai Jiaotong University, Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 years; 2. According to the diagnostic criteria of PICS: ICU stay > 10 days, inflammation index: CRP > 150 Hg/dl, retinol binding protein concentration < 1 mg/dL, immunosuppressive state: lymphocyte count < 0.8 * 10^9/L, high catabolism state: plasma albumin level < 3.0 g/dl, creatinine height index < 80%, weight loss 10%. Or BMI<18 during the whole hospitalization.

Exclusion criteria

Exclusion criteria: 1. hormone or immunosuppressive agents used in the past month; 2. chronic diseases such as tumors;

Design outcomes

Primary

MeasureTime frame
Mortality;Immunity function;

Countries

China

Contacts

Public ContactLiu Jiao

Ruijin Hospital North Compus, Shanghai Jiaotong University, Medical School

catherine015@163.com+86 18121266339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026